JPRN-UMIN000021325
Completed
未知
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal metastasis from colorectal or appendiceal cancer: a feasibility study - Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal metastasis from colorectal or appendiceal cancer: a feasibility study
ational Center for Global Health and Medicine0 sites10 target enrollmentMarch 3, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Peritoneal metastasis from colorectal or appendiceal cancer
- Sponsor
- ational Center for Global Health and Medicine
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patient who has a history of multiple cancers within 5 years before registration, with the exception of carcinoma in situ and a disease equivalent to intramucosal carcinoma. 2\) Patient who is associated with unstable angina pectoris that occurred or worsened within 3 weeks before registration, or patient with a history of cardiac infarction that developed within 6 months before registration. 3\) Patient with serious diseases including uncontrolled congestive cardiac failure and abnormal cardiac rhythm. 4\) Patient who is associated with or has a history of either fibroid lung or interstitial pneumonia or both. Patient with imaging findings suggestive of the diseases. 5\) Patient who is pregnant or breast feeding, or who refuses to use appropriate birth control. 6\) Patient whose consent is suspicious in terms of his/her mental and legal state. 7\) Patient who is considered by the investigator to be unsuitable for enrollment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A prospective interventional study for pseudomyxoma peritoneiJPRN-jRCTs031180254Gohda Yoshimasa75
Active, not recruiting
Phase 1
Cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) in patients with peritoneal carcinomatosis from ovarian cancer , fallopian tube or primary peritoneal carcinoma : randomized clinical trial.EUCTR2011-001715-31-ESFundación para la Formación e Investigación Sanitaria de la Región de Murcia126
Completed
Not Applicable
Evaluating the effect of reducing the number of cancer cells and intraperitoneal chemotherapy in patients with advanced peritoneal carcinomaeoplasm.Malignant neoplasm of ovaryIRCT201112088331N1Mashhad University of Medical Sciences20
Completed
Not Applicable
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy versus R0 Resection for Resectable Colorectal Cancer with Peritoneal Metastases with Low Peritoneal Cancer Index Score: A Collaborative Observational Study from Korea and JapaColorectal Cancer with Peritoneal MetastasesJPRN-UMIN000051539Yonsei University College of Medicine166
Active, not recruiting
Phase 1
Surgery and abdominal chemotherapy for patient with peritoneal metastasized stomach cancerPeritoneal carcinomatosis of gastric originMedDRA version: 20.0 Level: LLT Classification code 10017767 Term: Gastric cancer stage IV with metastases System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-002595-27-NLniversity Medical Center Utrecht20